|1.||Ferrone, Soldano: 39 articles (10/2015 - 05/2003)|
|2.||Seliger, Barbara: 16 articles (05/2013 - 05/2003)|
|3.||Seliger, B: 8 articles (12/2001 - 05/2000)|
|4.||Abhyankar, Dhiraj: 6 articles (04/2005 - 08/2003)|
|5.||Krishnakumar, Subramanian: 6 articles (04/2005 - 08/2003)|
|6.||Biswas, Jyotirmay: 6 articles (04/2005 - 08/2003)|
|7.||Huber, C: 6 articles (12/2001 - 05/2000)|
|8.||Chang, Chien-Chung: 5 articles (10/2015 - 12/2003)|
|9.||Wang, Xinhui: 5 articles (06/2012 - 01/2005)|
|10.||Ogino, Takeshi: 5 articles (04/2010 - 09/2003)|
01/01/1991 - "Previous laboratory studies have suggested that natural immunity is a primordial defense mechanism against blood-borne metastatic cancer, its function being most effective against dedifferentiated, low-major-histocompatibility-complex-class-I-antigen-expressing tumors. "
11/11/1992 - "Recent studies have suggested that certain oncogenes, in particular members of the myc family, may be involved in the down-regulation of HLA class-I antigen expression observed in many types of tumor. "
04/01/1990 - "To study this problem the immunogenic MHC class I antigen, K216 was transfected into a progressor tumor. "
04/01/1986 - "The present studies indicate that splenic Lyt 1-, Lyt 2-, and L3T4-expressing cells regulate tumor cell MHC class I antigen expression, and that these cells require a genetically resistant host environment in which to differentiate. "
04/01/1986 - "Earlier studies have demonstrated that resistance to the tumor and regulation of tumor cell MHC class I antigen expression are under the control of the host's immune system. "
12/01/2014 - "Inflammatory cells that surround, invade and destroy healthy muscle fibers expressing MHC class I antigen are the typical pathological finding of polymyositis. "
07/01/2008 - "Polymyositis and sIBM showed MHC class I antigen positivity along sarcolemma of single and small groups of muscle fibers. "
10/01/1992 - "Muscle fibers strongly expressed the major histocompatibility complex class I antigen (2/2) as in polymyositis. "
01/01/2009 - "Remarkably, MHC-I antigen was expressed in the muscle membrane and most of the inflammatory cells were CD8-positive, suggesting that class-I antigen-dependent cytotoxic T-cells played a crucial role in the muscle pathology, which supported a diagnosis of polymyositis rather than dermatomyositis. "
01/01/1988 - "The amino acid sequence of histidyl-tRNA synthetase, the Jo-I antigen of polymyositis, has been compared with that of the polyprotein of encephalomyocarditis virus (EMCV), an agent shown recently to produce polymyositis symptoms in mice. "
|3.||Muscular Diseases (Myopathy)
09/01/2014 - "Results of a muscle biopsy showed necrotizing myopathy with minimal inflammatory cell infiltrate and increased major histocompatibility class I antigen expression in muscle fibers. "
11/01/1993 - "The myopathy caused by HIV and HTLV-1 is not due to direct infection of the muscle by these viruses, but rather due to an immunopathologic process triggered by the viruses, mediated by autoaggressive CD8+ cells in the context of MHC-class I antigen expression. "
03/01/1989 - "Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies."
01/01/1997 - "Immunohistology for major histocompatibility complex class I antigen and histochemical reaction for cytochrome coxidase are helpful in the correct classification of a myopathy as HIV polymyositis or zidovudine myopathy."
11/01/1995 - "Immunohistology for major histocompatibility complex class I antigen and histochemical reaction for cytochrome c oxidase are helpful in correct classification of a myopathy as HIV polymyositis or zidovudine myopathy."
|4.||Melanoma (Melanoma, Malignant)
05/01/2005 - "In the present study, we have utilized this panel of mAbs to analyze the expression of HLA class I allospecificities in 33 primary and in 11 metastatic lesions surgically removed from HLA-typed patients with malignant melanoma, as this information contributes to determine the extent of HLA class I antigen abnormalities in melanoma lesions. "
08/01/2002 - "In this study, we analyzed HLA-I antigen expression of uveal melanomas to determine whether a relationship exist between antigenic expression and melanoma cell type. "
05/01/2011 - "Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines."
05/01/2008 - "To describe the frequency and distribution of different types of HLA class I antigen alterations in 91 melanoma cell lines from the European Searchable Tumour Cell and Databank (ESTDAB). "
01/01/2008 - "Our data suggest that reduced TAP1, TAP2 and HLA class I antigen protein expression in MM may contribute to the immune escape phenotype of human melanoma cells, and the main cause of reduced HLA class I expression may be the decreased TAP1 and TAP2 levels."
04/01/2011 - "The objective of this study was to determine whether immunization of Mozambique tilapia with different Cryptocaryon irritans i-antigen serotypes elicited cross-protection against challenge infection by both serotypes. "
12/01/1988 - "The aim of this study was to investigate whether I antigen occurs in association with Mycoplasma pneumoniae in a form that may be immunogenic during natural infection or experimental immunization. "
08/01/2014 - "Dendritic cell maturation in HCV infection: altered regulation of MHC class I antigen processing-presenting machinery."
05/01/2012 - "Thus, NLRC5 critically regulates MHC class I antigen presentation to control intracellular pathogen infection."
02/01/2011 - "The loss of expression of HLA-I antigen was significantly correlated with part of the APM components and positively correlated with high risk HPV16 infection. "
|2.||Electron Transport Complex IV (Cytochrome c Oxidase)
|4.||Histocompatibility Antigens Class II
|5.||Proteins (Proteins, Gene)
|9.||Aspirin (Acetylsalicylic Acid)
|2.||Drug Therapy (Chemotherapy)
|4.||Homologous Transplantation (Allograft)
|5.||Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)